 |
Business Excellence - Actavis Group
|
    |
The Actavis Group is a leading player in the development, manufacture and sale of high-quality generic pharmaceuticals.
Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries. Founded in 1956, the Group now operates across five continents and has its headquarters in Iceland.
Today the Company has modern development and manufacturing facilities in Europe, the US and Asia. The plants produce a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi solids.
The Group has one of the broadest portfolios in the generics sector with over 600 products on the market, in addition to over 200 products in the development pipeline and in registration, enabling the Company to provide its customers with a wide range of affordable high quality pharmaceuticals.
An extensive network of sales and marketing offices enables effective market penetration, and positions the Company in a leading position in the largest markets for generic pharmaceutical products. Strategic acquisitions, the opening of new sales offices and intensive investment in the development of generic pharmaceuticals are fuelling the growth of Actavis and have positioned the Group to take advantage of future opportunities.
The Group remains committed to leading the consolidation of a still fragmented industry through strategic acquisitions, and to driving further organic growth through innovative product launches, penetration of new markets and regulatory approvals of new generic pharmaceuticals. It continues to invest heavily in research and development and pursue a determined first-to-market strategy.
Actavis is a financially strong and profitable business that has experienced rapid growth and good profitability in recent years. Actavis is a listed company on the Icelandic Stock Exchange Actavis, with a market capitalization over US$2 billion as of December 2005.
The Group’s head office is in Iceland and regional headquarters are located in Denmark and the US.
Corporate Vision
Actavis’ vision is to be a leading company in the sales, development and manufacturing of quality generic pharmaceuticals in the international market. Actavis aims to offer better and faster access to the latest generic products and a wide portfolio of affordable, high-quality pharmaceuticals.
Contact Info
Head Office
Reykjavikurvegur 76-78
220 Hafnarfjordur
Iceland
Tel.: +354 535 2300
Fax: +354 535 2301
E-mail: actavis@actavis.com
Website: www.actavis.com
More Info